DE3576359D1 - Verfahren zur herstellung von tumorspezifische monoklonale antikoerper produzierenden hybridomazellen. - Google Patents

Verfahren zur herstellung von tumorspezifische monoklonale antikoerper produzierenden hybridomazellen.

Info

Publication number
DE3576359D1
DE3576359D1 DE8585301678T DE3576359T DE3576359D1 DE 3576359 D1 DE3576359 D1 DE 3576359D1 DE 8585301678 T DE8585301678 T DE 8585301678T DE 3576359 T DE3576359 T DE 3576359T DE 3576359 D1 DE3576359 D1 DE 3576359D1
Authority
DE
Germany
Prior art keywords
producing
monoclonal antibody
hybridoma cells
specific monoclonal
tumor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8585301678T
Other languages
English (en)
Inventor
Hajime Yoshida
Nobuo Hanai
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
KH Neochem Co Ltd
Original Assignee
Kyowa Hakko Kogyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyowa Hakko Kogyo Co Ltd filed Critical Kyowa Hakko Kogyo Co Ltd
Application granted granted Critical
Publication of DE3576359D1 publication Critical patent/DE3576359D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3023—Lung
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3046—Stomach, Intestines
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/806—Drug, bio-affecting and body treating compositions involving IgM
    • Y10S424/807—Monoclonal
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/806—Antigenic peptides or proteins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/808—Materials and products related to genetic engineering or hybrid or fused cell technology, e.g. hybridoma, monoclonal products
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/828—Cancer
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/863—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving IgM
    • Y10S530/864—Monoclonal

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE8585301678T 1984-03-12 1985-03-11 Verfahren zur herstellung von tumorspezifische monoklonale antikoerper produzierenden hybridomazellen. Expired - Lifetime DE3576359D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP59046683A JPS60190721A (ja) 1984-03-12 1984-03-12 抗腫瘍特異的単クロ−ン性抗体の製造法

Publications (1)

Publication Number Publication Date
DE3576359D1 true DE3576359D1 (de) 1990-04-12

Family

ID=12754172

Family Applications (2)

Application Number Title Priority Date Filing Date
DE8585301678T Expired - Lifetime DE3576359D1 (de) 1984-03-12 1985-03-11 Verfahren zur herstellung von tumorspezifische monoklonale antikoerper produzierenden hybridomazellen.
DE198585301678T Pending DE156578T1 (de) 1984-03-12 1985-03-11 Verfahren zur herstellung von tumorspezifische monoklonale antikoerper produzierenden hybridomazellen.

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE198585301678T Pending DE156578T1 (de) 1984-03-12 1985-03-11 Verfahren zur herstellung von tumorspezifische monoklonale antikoerper produzierenden hybridomazellen.

Country Status (5)

Country Link
US (1) US4892934A (de)
EP (1) EP0156578B1 (de)
JP (1) JPS60190721A (de)
CA (1) CA1312024C (de)
DE (2) DE3576359D1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5552291A (en) * 1985-10-09 1996-09-03 Kyowa, Hakko Kogyo Co., Ltd. Anti-human pulmonary adenocarcinoma specific monoclonal antibody
JPS6283898A (ja) * 1985-10-09 1987-04-17 Kyowa Hakko Kogyo Co Ltd 抗ヒト肺腺癌特異的単クロ−ン性抗体
US4816402A (en) * 1986-01-07 1989-03-28 Northwestern University Murine hybridoma and diagnostic antibody produced thereby
JPS62207298A (ja) * 1986-03-06 1987-09-11 Kyowa Hakko Kogyo Co Ltd 抗ヒト胃癌単クロ−ン性抗体
JPS6319561A (ja) * 1986-07-11 1988-01-27 Kyowa Hakko Kogyo Co Ltd 抗ヒト肺癌単クロ−ン性抗体
JPH0673470B2 (ja) * 1986-07-15 1994-09-21 協和醗酵工業株式会社 抗ヒト胃癌単クロ−ン性抗体ａｍｃ−４６２
JPS63157995A (ja) * 1986-12-18 1988-06-30 Kyowa Hakko Kogyo Co Ltd 抗ヒト大腸癌単クロ−ン性抗体ａｃｃ−５７４
US5580740A (en) * 1988-03-28 1996-12-03 Kyowa Hakko Kogyo Co., Ltd. Antihuman pulmonary adenocarcinoma monoclonal antibody
JPH01277498A (ja) * 1988-04-28 1989-11-07 Kyowa Hakko Kogyo Co Ltd 抗ヒト胃癌モノクローナル抗体ａｍｃ−８４
DE69432926T2 (de) * 1993-02-05 2004-05-13 Epigen, Inc., Wellesley Humanes carcinoma-antigen (hca), hca antikörper, hca immunoassays, aufzeichnungsmethoden und therapy
US8071322B2 (en) * 2002-11-12 2011-12-06 Epitomics, Inc. Method for identifying differentially expressed proteins
US20080008699A1 (en) * 2005-10-28 2008-01-10 Jianxun Li Method for proteomic analysis utilizing immune recognition and cumulative subtraction

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4172124A (en) * 1978-04-28 1979-10-23 The Wistar Institute Method of producing tumor antibodies
US4427653A (en) * 1981-01-26 1984-01-24 President And Fellows Of Harvard College Method of making monoclonal antibodies
US4650756A (en) * 1981-08-31 1987-03-17 Sloan Kettering Institute For Cancer Research Monoclonal antibodies to cell surface antigens of human renal cancer
DE3211356A1 (de) * 1982-03-27 1983-09-29 Behringwerke Ag, 3550 Marburg Zell-hybrid, verfahren zu seiner herstellung sowie seine verwendung
US4513088A (en) * 1983-03-30 1985-04-23 The Board Of Trustees Of The Leland Stanford Junior University Assay for monoclonal antibody against surface Ig of a human B cell tumor
US4666845A (en) * 1983-12-16 1987-05-19 Sloan-Kettering Institute Monoclonal antibodies to ovarian, cervical and uterine human cancers and method of diagnosis
GR850552B (de) * 1984-03-07 1985-07-05 Du Pont

Also Published As

Publication number Publication date
DE156578T1 (de) 1986-05-22
EP0156578A2 (de) 1985-10-02
JPS60190721A (ja) 1985-09-28
EP0156578A3 (en) 1987-11-25
US4892934A (en) 1990-01-09
EP0156578B1 (de) 1990-03-07
CA1312024C (en) 1992-12-29

Similar Documents

Publication Publication Date Title
DE3587360D1 (de) Verfahren zur herstellung von chimaerischen monoklonalen antikoerpern.
DE3587442D1 (de) Verfahren zur herstellung von polysilsesquioxanen.
DE3584482D1 (de) Verfahren zur herstellung elektrophoren gelmaterials.
DE3581200D1 (de) Verfahren zur herstellung von 1-hydroxyvitamin-d-verbindungen.
DE3585687D1 (de) Verfahren zur herstellung von 1-hydroxyvitamin-d-verbindungen.
DE3585052D1 (de) Verfahren zur herstellung von l-isoleucin durch fermentation.
DE3486147D1 (de) Verfahren zur herstellung von l-isoleucin.
DE3689734T2 (de) Gereinigter immunoglobulinbezüglicher Faktor, monoklonale Antikörper, Hybridoma-Zellinien, Verfahren und Verwendungen.
DE3575728D1 (de) Verfahren zur herstellung kristallisierten maltitols.
DE3575423D1 (de) Verfahren zur herstellung von heteroaryloxyacetamiden.
DE3586638T2 (de) Verfahren zur herstellung von vanadylphthalocyanin.
DE3578062D1 (de) Verfahren zur herstellung von iodbenzol.
DE3577854D1 (de) Verfahren zur herstellung von aethylenkopolymer.
DE3576359D1 (de) Verfahren zur herstellung von tumorspezifische monoklonale antikoerper produzierenden hybridomazellen.
DE3580626D1 (de) Verfahren zur herstellung von schleifmitteln.
DE3580513D1 (de) Verfahren zur isolierung von monoklonalen antikoerpern aus hybridomas-kulturen.
DE3580611D1 (de) Verfahren zur herstellung alkoholischer getraenke.
DE3381934D1 (de) Verfahren zur herstellung von shampoos.
DE3485128D1 (de) Zellinien verwendbar zur herstellung von hybridomazellen.
DE3584173D1 (de) Verfahren zur herstellung von l-phenylalanin.
DE3381203D1 (de) Verfahren zur herstellung von uridindiphosphat-n-acetylgalactosamin.
DE3585219D1 (de) Verfahren zur herstellung von n-formyl-alpha-aspartyl-phenylalaninen.
DE3382369D1 (de) Verfahren zur herstellung von blockcopolyamiden.
DE3579858D1 (de) Verfahren zur herstellung von p-isobutylstyrol.
DE3575133D1 (de) Verfahren zur herstellung von 1-alkyl- oder 1-cycloalkylpiperazinen.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee